| Drug rash with eosinophilia and systemic symptoms | Causes | Medication exposure | 1.00 | infobox |
| Drug rash with eosinophilia and systemic symptoms | Complications | Kidney damage, liver damage, heart damage, lung damage | 1.00 | infobox |
| Drug rash with eosinophilia and systemic symptoms | Diagnostic method | Clinical diagnosis. | 1.00 | infobox |
| Drug rash with eosinophilia and systemic symptoms | Differential diagnosis | Stevens Johnson syndrome, Toxic epidermal necrolysis, Acute generalized exanthematous pustulosis | 1.00 | infobox |
| Drug rash with eosinophilia and systemic symptoms | Frequency | Incidence 1 case per 1,000 people to 1 case per 10,000 people | 1.00 | infobox |
| Drug rash with eosinophilia and systemic symptoms | Other names | Drug induced hypersensitivity syndrome (DIHS), drug hypersensitivity syndrome (DHS), drug-induced delayed multiorgan hypersensitivity syndrome, drug-induced pseudolymphoma (form… | 1.00 | infobox |
| Drug rash with eosinophilia and systemic symptoms | Prognosis | Mortality rate varies, generally 1.2-7.1%, long term complications or disability is common | 1.00 | infobox |
| Drug rash with eosinophilia and systemic symptoms | Risk factors | Certain Human leukocyte antigen variants confer a greater risk after medication exposure | 1.00 | infobox |
| Drug rash with eosinophilia and systemic symptoms | Specialty | Dermatology, Immunology | 1.00 | infobox |
| Drug rash with eosinophilia and systemic symptoms | Symptoms | Rash, fever, sore throat, lymph node swelling, sores in mouth or other mucosal surfaces, facial swelling, itching | 1.00 | infobox |
| Drug rash with eosinophilia and systemic symptoms | Treatment | Discontinuing the offending medication, supportive care, glucocorticoids, Anti IL-5 antibodies, immunosuppressants | 1.00 | infobox |
| Drug rash with eosinophilia and systemic symptoms | Usual onset | Usually 2-6 weeks after drug exposure | 1.00 | infobox |
